Adolescence to early adulthood transition in French severe asthmatic children treated with omalizumab
C. Taillé (Paris, France), M. Humbert (Le Kremlin-Bicêtre, France), A. Bourdin (Montpellier, France), R. Niarra (Rueil Malmaison, France), C. Thonnelier (Rueil Malmaison, France), A. Lajoinie (Lyon, France), A. Rigault (Lyon, France), M. Molimard (Bordeaux, France), A. Deschildre (Lille, France)
Source: International Congress 2022 – Asthma treatment: real-world studies and other diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Taillé (Paris, France), M. Humbert (Le Kremlin-Bicêtre, France), A. Bourdin (Montpellier, France), R. Niarra (Rueil Malmaison, France), C. Thonnelier (Rueil Malmaison, France), A. Lajoinie (Lyon, France), A. Rigault (Lyon, France), M. Molimard (Bordeaux, France), A. Deschildre (Lille, France). Adolescence to early adulthood transition in French severe asthmatic children treated with omalizumab. 1332
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|